BRWM
ACHN

B. Riley Wealth Management’s Achillion Pharmaceuticals ACHN Stock Holding History

B. Riley Wealth Management’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-400
Closed -$3K – 877
2015
Q2 		$3K Hold
400
– – ﹤0.01% 943
2015
Q1 		$3K Hold
400
– – ﹤0.01% 943
2014
Q4 		$4K Hold
400
– – ﹤0.01% 891
2014
Q3 		$3K Sell
400
-1,000
-71% -$9.28K ﹤0.01% 968
2014
Q2 		$10K Hold
1,400
– – 0.01% 831
2014
Q1 		$5K Buy
+1,400
New +$4.9K ﹤0.01% 896

Other funds holding ACHN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

B. Riley Wealth Management's ACHN Position: Q3 2015 in Review

B. Riley Wealth Management sold out of Achillion Pharmaceuticals (ACHN) in Q3 2015, closing a stake of 400 shares — an estimated $3K sold.

B. Riley Wealth Management first reported a position in ACHN in Q1 2014 and held it in 6 quarters. The position peaked at $10K in Q2 2014. 141 funds tracked by Wall St. Rank hold ACHN as of Q3 2015.

  • B. Riley Wealth Management reported no remaining Achillion Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • B. Riley Wealth Management sold 400 Achillion Pharmaceuticals shares in Q3 2015, an estimated $3K.
  • B. Riley Wealth Management first reported a position in Achillion Pharmaceuticals in Q1 2014 and held it in 6 quarters.
  • B. Riley Wealth Management's Achillion Pharmaceuticals position peaked at $10K in Q2 2014.
  • 141 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q3 2015.

Based on B. Riley Wealth Management's 13F filing for Q3 2015, filed 13 Oct 2015.